Mutation or deletion of one of the two genes encoding a protein known as SMN has recently been shown to cause spinal muscular atrophy. The SMN protein has been found to be part of a multi-component complex that appears to function in the assembly of cellular ribonucleoprotein particles.
Spinal muscular atrophy is one of the most common human autosomal recessive disorders. In spinal muscular atrophy patients, motor neurons from the anterior horn of the spinal cord degenerate, resulting in the loss of muscle innervation and subsequent muscular atrophy. Three forms of spinal muscular atrophy, types I, II and III, have been distinguished on the basis of the severity; only type III patients have a chance of survival beyond infancy (reviewed in [1] ). Until recently, the genetics of spinal muscular atrophy had been too complex to understand, but the identification of the disease gene, called survival motor neuron or SMN [2] , has now allowed progress to be made in this area. This progress establishes a connection with a surprising aspect of cell biology -the assembly of ribonucleoprotein (RNP) particles.
The human SMN locus is part of a large inverted duplication on chromosome 5, with one copy of the gene being present in each repeat. The two gene copies encode identical amino acid sequences, and both are expressed ( [3] and references therein). They are therefore distinguished by their location as the SMN C (centromeric) and SMN T (telomeric) genes. The duplication event appears to be relatively recent; mice, for example, have a single SMN gene. Moreover, the duplicated human locus is highly polymorphic [4] , and this genetic instability probably explains the high frequency of spinal muscular atrophy.
Patients lacking both SMN C and SMN T have not been reported, suggesting that deletion of both genes causes embryonic death. Individuals lacking just SMN C , however, are normal; the vast majority of spinal muscular atrophy patients have abnormalities associated with the SMN T locus. The most severely affected (spinal muscular atrophy type I) patients either lack SMN T , as a result of a chromosomal deletion, or have specific mutations in this copy of the gene [1, 4] . Patients with spinal muscular atrophy types II or III have other, presumably less deleterious, mutations in SMN T , including cases where all or part of the SMN T gene is replaced by a second copy of the SMN C locus as a result of gene conversion, an event that can be accompanied by the generation of additional SMN C copies [1, 4] . Thus, the presence of two or even more copies of SMN C does not compensate for the loss of SMN T .
The mutations that cause spinal muscular atrophy appear to have similar effects on SMN protein production. Although some tissues or cell lines derived from spinal muscular atrophy patients still produce SMN protein at near-normal levels, other tissues, like liver or, notably, spinal motor neurons, either lack or have greatly reduced levels of SMN protein [3, 5] . The simplest explanation for these observations is that spinal muscular atrophy is caused by insufficient production of SMN protein in motor neurons, which appear to express higher levels of SMN than other cell types [3, 5] . This can be the result of mutation of either the SMN T protein or of an element required for the expression -acting at the level of transcription, processing, nuclear export, translation or stability -of SMN T mRNA. According to this view, the specificity of the effects on motor neurons would reflect a quantitatively greater requirement for SMN in these cells to carry out a general 'housekeeping' function. But as expression in other tissues, such as liver, is also greatly reduced in spinal muscular atrophy patients [5] , it is also possible that SMN has a specific function in motor neurons, and that loss of this function underlies spinal muscular atrophy.
SMN's partners
What might the function of SMN be? The first clue came from a serendipitous observation made in a 'two-hybrid' screen for proteins that will interact with SMN in yeast cells. SMN was found to interact specifically with an RNA-binding protein, suggesting that its function might be related to RNA metabolism [6] . This possibility received some support from the intracellular location of SMN. Although SMN was found throughout the cell, it was most concentrated in a small number (three to eight) of structures found scattered in the nucleus [6] . These structures were frequently located adjacent to so-called 'coiled bodies', and were thus christened 'gemini of coiled bodies' or gems.
The function of coiled bodies is not known, but their relationship to RNP particles is well established. Coiled bodies contain high concentrations of the U small nuclear (sn)RNPs, which are involved in nuclear pre-mRNA processing, as well as components of the small nucleolar (sno)RNPs, which play a role in pre-ribosomal RNA metabolism [7] . The proximity of gems and coiled bodies implied that gems might also have some association with this group of RNPs. This implication has been confirmed in two recent papers [8, 9] and evidence that the SMN protein may function in RNP assembly has been presented.
These studies began with another two-hybrid screen, this time using the SMN protein itself as a bait. A protein called SIP1 ('SMN interacting protein 1') was selected and shown to interact directly with SMN in vitro [8] .
Immunolocalisation of SIP1 revealed a distribution identical to that of SMN, with a low concentration throughout the cell and intense staining of gems. Immunoprecipitation of human cell extracts with either SMN or SIP1 antibodies co-precipitated the other protein, demonstrating their association in vivo. The SMN-SIP1 complexes were found to be very large, roughly 300 kDa. They contain numerous stably bound components apart from SMN and SIP1, several of which were shown to be U snRNP proteins [8] .
U snRNPs function in the maturation of mRNA precursors. They consist of one or two RNA molecules and a number of proteins. The proteins can be divided into two general classes: specific proteins that are uniquely associated with one of the U snRNAs and common proteins that associate with all U snRNAs [10, 11] . The common proteins all contain a related domain, the Sm domain, so named because it is recognised by autoimmune sera of the Sm serotype (reviewed in [12] ). All but two of these Sm proteins bound recombinant SMN protein when translated in vitro and incubated with SMN [8] . This implies an interaction between SMN and the Sm domain, but as these experiments involved the use of reticulocyte lysates, they do not prove direct interaction. SIP1 did not interact with the Sm proteins in similar assays. Evidence that these in vitro interactions reflect in vivo function came from the presence of U snRNAs or U snRNP proteins in SMN or SIP1 immunoprecipitates of cytoplasmic fractions of Xenopus laevis oocytes or whole cell extracts of HeLa cells, respectively [8, 9] .
SMN and U snRNP assembly
In vertebrates, U snRNP assembly involves transcription of the pre-U snRNA and its export to the cytoplasm. There, the RNA joins with the Sm proteins, allowing further events involved in the maturation of U snRNPs to occur, including the formation of the trimethyl cap structure on the U snRNAs [10, 11] . Xenopus oocytes have been favourite cells for the study of U snRNP assembly, as massive quantities of the Sm proteins are stored in the oocyte cytoplasm for use during early embryogenesis [10] . Like the Sm proteins, SMN and SIP1 have a different location in oocytes and somatic cells, being almost entirely cytoplasmic in oocytes. Association of SMN and SIP1 with newly assembled U snRNPs could be demonstrated in the cytoplasm, but not the nucleus, of oocytes [9] . This suggested that SMN and SIP1 are involved in U snRNP assembly, a hypothesis that was tested by introducing U snRNAs into the oocyte cytoplasm by microinjection. The assembly of the U snRNAs into U snRNPs was monitored in the presence of antibodies specific for SMN or SIP1. Remarkably, both antibodies affected U snRNP assembly. The most dramatic effect was caused by the antibodies against SIP1, which efficiently blocked the assembly of U1, U2, U4 and U5 snRNPs. Conversely, the antibodies against SMN stimulated U snRNP formation [9] . These effects were not specific for a particular U snRNA and were interpreted as evidence that SMN and SIP1 have a role in U snRNP assembly [9] , perhaps equivalent to that played by chaperonins in multi-protein complex assembly. If this were indeed the case, SMN and SIP1 will be the first identified cellular RNP assembly factors that are not part of the RNP particle that they help assemble. If for no other reason, they are therefore extremely interesting proteins.
There are obvious questions raised by these findings. What has U snRNP assembly, a cytoplasmic event, got to do with gems, the sites of highest SMN and SIP1 concentration? The answer might be "more than we would imagine". If mutant forms of either SMN or SIP1 are made in mammalian cells, large aggregates containing SMN and SIP1 form in both nucleus and cytoplasm. Among many other coiled-body components, the nuclear aggregates contain mature, trimethylated U snRNAs (G. Dreyfuss, personal communication). This supports the initial contention [6] that gems and coiled bodies may be functionally related, and that U snRNPs, although not detectably associated with SMN or SIP1 in the nucleus at steady state, might transiently interact with them (an interaction that might be stabilized by mutation of SMN or SIP1, causing aggregation). In turn, this would suggest that SMN and SIP1 could be involved in recycling U snRNPs in the nucleus, a function related to U snRNP assembly in the cytoplasm.
What about the specificity of the effects in spinal muscular atrophy of SMN underexpression in motor neurons compared with other tissues, such as liver, that seem to show similarly reduced expression [5] . This may reflect a greater need for SMN in motor neurons, where both SMN and SIP1 are particularly highly expressed [3, 5] . However, there is a second possibility worth considering. Two of the Sm proteins that are abundant in HeLa cell U snRNPs, B and B′, are barely expressed in neurons, where they are replaced by a neuron-specific Sm protein.
Perhaps the neuron-specific Sm protein interacts differently with SMN; if so, the choice of name for this protein was prophetic, as it is called SmN [13] .
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Perspectives
Analysis of the as yet uncharacterised protein components of the SMN-SIP1 complex may provide new clues to its function. It will be of interest to examine the effects of SMN and SIP1 on the assembly of other RNPs, including nucleolar RNPs that assemble in the nucleus and splicing complexes that assemble on mRNA precursors. Additional studies of the effects of mutant forms of the proteins on mammalian cells may provide further insight into the relationship between gems, coiled bodies and nuclear components involved in RNA metabolism. Aside from this, the existence of an obvious SMN homologue in Schizosaccharomyces pombe [14] and of a very distant, but provocative, relationship between SIP1 and the Saccharomyces cerevisiae protein Brr1, which has been implicated in U snRNP assembly in that organism [15] , suggests that a conventional genetic approach to SMN and SIP1 function will be both possible and rewarding.
Finally, the existence of an in vitro U snRNP assembly system [16] will provide the possibility for a direct biochemical test of the role of SMN and SIP1 in this process. Although U snRNP assembly in vitro occurs in the apparent absence of SMN and SIP1 [16] , it is not efficient. Perhaps immunopurified SMN-SIP1 complexes will support assembly in a manner that more closely resembles the in vivo situation. Not for the first time, very specific pathological defects may turn out to be derived from defects in a very general biological process.
